S100A7 Protein (Fc Tag)

Produktnummer ABIN7536475

Produktdetails

Target: S100A7 (S100 Calcium Binding Protein A7 (S100A7))

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses S100A7 Protein ist gelabelt mit Fc Tag.

Verwendungszweck: Recombinant Human S100-A7 Protein

Sequenz: SNTQAERSII GMIDMFHKYT RRDDKIEKPS LLTMMKENFP NFLSACDKKG TNYLADVFEK KDKNEDKKID FSEFLSLLGD IATDYHKQSH GAAPCSGGSQ

Spezifität: Ser2-Gln101

Reinheit: > 97 % by SDS-PAGE.

Sterilität: 0.22 μm filtered

Endotoxin-Niveau: < 0.01EU/μg

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid votex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1 % BSA, 5 % HSA, 10 % FBS or 5 % Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.

Konzentration: 1.48 mg/mL

Buffer: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Store the lyophilized protein at -20°C to -80°C for 12 months.|After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week.

Antigendetails

Target: S100A7 (S100 Calcium Binding Protein A7 (S100A7))

Andere Bezeichnung: S100-A7 (S100A7 Produkte)

Synonyme: PSOR1 Protein, S100A7c Protein, S100A7 Protein, S100 calcium binding protein A7 Protein, protein S100-A7 Protein, S100A7 Protein, LOC469501 Protein, LOC713189 Protein, LOC714943 Protein, LOC101104285 Protein, LOC102191570 Protein

Hintergrund:

Description: Protein S100-A7, also known as S100 calcium-binding protein A7, Psoriasin, S100A7, and PSOR1, is a secreted protein which belongs to theS-100 family. S100A7 was first isolated from skin involved by psoriasis, which can be induced in cultured squamous epithelial cells. S100A7 is expressed by both normal cultured and malignant keratinocytes and malignant breast epithelial cells within ductal carcinoma in situ, suggesting an association with abnormal pathways of differentiation. S100A7 plays a role in the pathogenesis of inflammatory skin disease, as a chemotactic factor for hematopoietic cells. It also plays a role in early stages of breast tumor progression in association with the development of the invasive phenotype.

Name: PSOR1, S100A7c,S100-A7,S100A7

Gen-ID: 6278

UniProt: P31151

Pathways: S100 Proteine